Taekwang Industrial Takes 36.8% Stake in Nissho Kai

The Korean firm's 35.1 billion won investment expands its footprint in Japan's hair loss treatment market.

Updated on Nov. 18, 2026 in Healthcare

Taekwang Industrial Takes 36.8% Stake in Nissho Kai

Live Poll

Do you trust big companies to keep their healthcare promises to customers?

Taekwang Industrial invested 35.1 billion Korean won for a 36.8% stake in Nissho Kai, the operator of Japan's Doctor AGA Clinics. The acquisition, carried out with Invictus PEF and Wontek, was completed on September 30.

Why it matters

The investment is intended to expand business synergies with affiliates by leveraging Taekwang Industrial's local medical network in Japan. It extends the company's strategy to grow its beauty and healthcare business across international markets.

Taekwang Industrial invested 35.1 billion won for a 36.8% stake, within a total deal cost of about 10.8 billion yen (roughly 90.3 billion won) shared with Invictus PEF and Wontek. The operator currently runs 15 clinics in Japan, and the filing does not disclose projected revenue or profit contribution from the stake.

The players

Taekwang Industrial

A Korean industrial company that has been expanding into beauty and healthcare, including its recent acquisitions of Aekyung Industry and Dongsung Bio Pharm.

Nissho Kai

The operator of Japan's Doctor AGA Clinic network, which runs 15 hair loss treatment clinics across the country.

The details

The stake was acquired through a stock purchase agreement signed on September 21, with completion following on September 30. Taekwang Industrial formed a consortium with Invictus PEF and Wontek to execute the acquisition of Nissho Kai and Nissho Medical.

Timeline

  1. September 21: Stock purchase agreement signed for the acquisition.

  2. September 30: Stake acquisition completed.

  3. July: Taekwang Industrial launched a consultative body to review joint product production and raw material purchases.

  4. November 2026: A consultative body on product supply and OEM feasibility was formed.

  5. 2029: Target to expand from 15 to 25 clinics across Japan.

Market Landscape

Japan's AGA clinic market is projected to grow at an average annual rate of 8% until 2028, and Taekwang's stake places it inside that expansion. The move also aligns with its push to supply hair loss treatments and haircare products through its affiliated Korean companies.

For consumers, the deal may eventually affect the range and availability of hair loss treatments and haircare products sold through Doctor AGA Clinics. Any change in pricing or product access will depend on the joint product plans still under review.

The takeaway

Investments like this show how Asian beauty and healthcare companies are using local clinic networks to extend product lines into new markets. Watch for the joint product launches that will show whether the partnership delivers on its supply plans.

What happens next

Taekwang Industrial plans to expand the current 15 clinics to 25 across Japan by 2029, and is reviewing plans to jointly develop private brand products with Doctor AGA Clinic.

Further reading

For more on the sector, explore Healthcare coverage on Wisevoter.

Source note: This article includes information reported by 조선일보.

Live Poll

Do you trust big companies to keep their healthcare promises to customers?